IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS - ANVISA Registration 10287411453
Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411453 and manufactured by manufacturer not specified. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Oct 21, 2029.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including VENTANA MEDICAL SYSTEM, INC, LEICA BIOSYSTEMS NEWCASTLE LTD, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
10287411453
25351490878201994
30280358000186
Company Information
Dates and Status
Oct 21, 2019
21/10/2029
09/18/2025 19:00:01
IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS
Marcador de Carcinoma de Pele e Melanona
Not specified
80000230032
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS
Marcador de Carcinoma de Pele e Melanona
AGILENT TECHNOLOGIES, INC.
80000230032
Dec 26, 2016
IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
Not specified
10337990046
Nov 23, 2020
IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990046
Nov 23, 2020
IMMUNOHISTOCHEMISTRY - MARKERS FOR SKIN CARCINOMAS AND MELANOMAS
Familia Cancer de Pele e Melanomas
Not specified
10287410787
May 18, 2009
VENTANA MEDICAL SYSTEM, INC• United States of America
LEICA BIOSYSTEMS NEWCASTLE LTD• United Kingdom
AGILENT TECHNOLOGIES, INC.• United States of America
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.• Singapore
CELL MARQUE CORPORATION• United States of America
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
VENTANA MEDICAL SYSTEM, INC
10287411678
Oct 23, 2023
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Anti-PRAME (EPR20330) Rabbit Monoclonal Primary Antibody
Not specified
10287411678
Oct 23, 2023
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
LEICA BIOSYSTEMS NEWCASTLE LTD
10337990046
Nov 23, 2020
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Família Anticorpo para Carcinoma de Pele e Melanoma
Not specified
10337990046
Nov 23, 2020
IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE PELE E MELANOMAS
Marcador de Carcinoma de Pele e Melanona
AGILENT TECHNOLOGIES, INC.
80000230032
Dec 26, 2016